Biology of visceral adipose tissue

Handbook of Obesity: Etiology and Pathophysiology, Second Edition

Volumn , Issue , 2003, Pages 589-614

  Fried, Susan K ^a   Ross, Robert R ^b  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b QUEEN S UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 8744262189     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (235)

1. Bouchard C, Despres JP, Mauriege P. Genetic and nongenetic determinants of regional fat distribution. Endocr Rev 1993; 14(1):72–93.
2. Katzmarzyk PT, Malina RM, Perusse L, Rice T, Province MA, Rao DC, Bouchard C. Familial resemblance for physique: heritabilities for somatotype components. Ann Hum Biol 2000; 27(5):467–477.
3. Kissebah AH, Krakower GR. Regional adiposity and morbidity. Physiol Rev 1994; 74(4):761–811.
4. Vague J. The degree of masculine differentiation of obesities: a factor determining predisposition to diabetes, atherosclerosis, gout and uric calculous disease. Am J Clin Nutr 1956; 4:20–34.
5. Vague J. La differentiation sexuelle: factueur determinant des formes del'obesite. Presse Med 1947; 55:339–340.
6. Krotkiewski M, Björntorp P, Sjöström L., Smith U. Impact of obesity on metabolism in men and women. Importance of regional adipose tissue distribution. J Clin Invest 1983; 72(3):1150–1162.
7. Despres JP, Nadeau A, Tremblay A, Ferland M, Moorjani S, Lupien PJ, Theriault G, Pinault S, Bouchard C. Role of deep abdominal fat in the association between regional adipose tissue distribution and glucose tolerance in obese women. Diabetes 1989; 38(3): 304–309.
8. Despres JP, Moorjani S, Lupien PJ, Tremblay A, Nadeau A, Bouchard C. Regional distribution of body fat, plasma lipoproteins, and cardiovascular disease. Arteriosclerosis 1990; 10(4):497–511.
9. Seidell JC, Bouchard C. Abdominal adiposity and risk of heart disease. JAMA 1999; 281(24):2284–2285.
10. Björntorp P. Hazards in subgroups of human obesity. Eur J Clin Invest 1984; 14(4):239–241.
11. Krotkiewski M, Sjöström L., Björntorp P, Smith U. Regional adipose tissue cellularity in relation to metabolism in young and middle-aged women. Metabolism 1975; 24(6):703–710.
12. Ostman J, Arner P, Engfeldt P, Kager L. Regional differences in the control of lipolysis in human adipose tissue. Metabolism 1979; 28(12):1198–1205.
13. Micheli H, Carlson LA, Hallberg D. Comparison of lipolysis in human subcutaneous and omental adipose tissue with regard to effects of noradrenaline, theophylline, prostaglandin E1 and age. Acta Chir Scand 1969; 135(8):663–670.
14. Carlson LA, Hallberg D, Micheli H. Quantitative studies on the lipolytic response of human subcutaneous and omental adipose tissue to noradrenaline and theophylline. Acta Med Scand 1969; 185(6):465–469.
15. Björntorp P. “Portal” adipose tissue as a generator of risk factors for cardiovascular disease and diabetes. Arteriosclerosis 1990; 10:493–496.
16. Frayn KN, Samra JS, Summers LK. Visceral fat in relation to health: is it a major culprit or simply an innocent bystander? Int J Obes Relat Metab Disord 1997; 21(12):1191–1192.
17. Jensen MD. Lipolysis: contribution from regional fat. Annu Rev Nutr 1997; 17:127–139.
18. Bergman RN, Van Citters GW, Mittelman SD, Dea MK, Hamilton-Wessler M, Kim SP, Ellmerer M. Central role of the adipocyte in the metabolic syndrome. J Inves Med 2001; 49(1):119–126.
19. Getty L, Panteleon AE, Mittelman SD, Dea MK, Bergman RN. Rapid oscillations in omental lipolysis are independent of changing insulin levels in vivo. J Clin Invest 2000; 106(3):421–430.
20. Masuzaki H, Paterson J, Shinyama H, Morton NM, Mullins JJ, Seckl JR, Flier JS. A transgenic model of viseral obesity and the metabolic syndrome. Science 2001; 294:2166–2170.
21. Montague CT, O'Rahilly S. The perils of portliness: causes and consequences of visceral adiposity. Diabetes 2000; 49(6):883–888.
22. Arner P. Regional differences in protein production by human adipose tissue. Biochem Soc Trans 2001; 29(Pt 2):72–75.
23. Perusse L, Rice T, Chagnon YC, Despres JP, Lemieux S, Roy S, Lacaille M, Ho-Kim MA, Chagnon M, Province MA, Rao DC, Bouchard C. A genome-wide scan for abdominal fat assessed by computed tomography in the Quebec Family Study. Diabetes 2001; 50(3):614–621.
24. Rossner S, Bo WJ, Hiltbrandt E, Hinson W, Karstaedt N, Santago P, Sobol WT, Crouse JR. Adipose tissue determinations in cadavers-a comparison between cross-sectional planimetry and computed tomography. Int J Obes 1990; 14(10):893–902.
25. Abate N, Burns D, Peshock RM, Garg A, Grundy SM. Estimation of adipose tissue mass by magnetic resonance imaging: validation against dissection in human cadavers. J Lipid Res 1994; 35(8):1490–1496.
26. Matsuzawa Y, Shimomura I, Nakamura T, Keno Y, Kotani K, Tokunaga K. Pathophysiology and pathogenesis of visceral fat obesity. Obes Res 1995; 3(suppl 2):187S-194S.
27. Baumgartner RN, Heymsfield SB, Roche AF, Bernardino M. Abdominal composition quantified by computed tomography. Am J Clin Nutr 1988; 48(4): 936–945.
28. Kvist H, Sjostrom L, Tylen U. Adipose tissue volume determinations in women by computed tomography: technical considerations. Int J Obes 1986; 10(1):53–67.
29. Rissanen J, Hudson R, Ross R. Visceral adiposity, androgens, and plasma lipids in obese men. Metabolism 1994; 43(10):1318–1323.
30. Ross R, Rissanen J, Pedwell H, Clifford J, Shragge P. Influence of diet and exercise on skeletal muscle and visceral adipose tissue in men. J Appl Physiol 1996; 81(6):2445–2455.
31. Ross R, Aru J, Freeman J, Hudson R, Janssen I. Abdominal adiposity and insulin resistance in obese men. Am J Physiol Endocrinol Metab 282:E657–663.
32. Abate N, Garg A, Peshock RM, Stray-Gundersen J, Grundy SM. Relationships of generalized and regional adiposity to insulin sensitivity in men. J Clin Invest 1995; 96(1):88–98.
33. Abate N, Garg A, Peshock RM, Stray-Gundersen J, Adams-Huet B, Grundy SM. Relationship of general ized and regional adiposity to insulin sensitivity in men with NIDDM. Diabetes 1996; 45(12):1684–1693.
34. Ross R, Leger L, Morris D, de Guise J, Guardo R. Quantification of adipose tissue by MRI: relationship with anthropometric variables. J Appl Physiol 1992; 72(2):787–795.
35. Ross R, Rissanen J. Mobilization of visceral and subcutaneous adipose tissue in response to energy restriction and exercise. Am J Clin Nutr 1994; 60(5): 695–703.
36. Smith SR, Lovejoy JC, Greenway F, Ryan D, deJonge L, De la Bretonne J, Volafova J, Bray GA. Contributions of total body fat, abdominal subcutaneous adipose tissue compartments, and visceral adipose tissue to the metabolic complications of obesity. Metabolism 2001; 50(4):425–435.
37. Han TS, Kelly IE, Walsh K, Greene RM, Lean ME. Relationship between volumes and areas from single transverse scans of intra-abdominal fat measured by magnetic resonance imaging. Int J Obes Relat Metab Disord 1997; 21(12):1161–1166.
38. Ross R, Shaw KD, Rissanen J, Martel Y, de Guise J, Avruch L. Sex differences in lean and adipose tissue distribution by magnetic resonance imaging: anthropometric relationships. Am J Clin Nutr 1994; 59(6): 1277–1285.
39. Kelley DE, Thaete FL, Troost F, Huwe T, Goodpaster BH. Subdivisions of subcutaneous abdominal adipose tissue and insulin resistance. Am J Physiol Endocrinol Metab 2000; 278(5):E941-E948.
40. Newby FD, Sykes MN, Digirolamo M. Regional differences in adipocyte lactate production from glucose. Am J Physiol 1988; 255(5 Pt 1):E716-E722.
41. Warden CH, Fisler JS, Shoemaker SM, Wen PZ, Svenson KL, Pace MJ, Lusis AJ. Identification of four chromosomal loci determining obesity in a multifactorial mouse model. J Clin Invest 1995; 95(4):1545–1552.
42. Digirolamo M, Fine JB, Tagra K, Rossmanith R. Qualitative regional differences in adipose tissue growth and cellularity in male Wistar rats fed ad libitum. Am J Physiol 1998; 274(5 Pt 2):R1460-R1467.
43. Fried SK, Lavau M, Pi-Sunyer FX. Variations of glucose metabolism by fat cells from three adipose depots of the rat. Metabolism 1982; 31(9):876–883.
44. Barzilai N, She L, Liu BQ, Vuguin P, Cohen P, Wang J, Rossetti L. Surgical removal of visceral fat reverses hepatic insulin resistance. Diabetes 1999; 48(1): 94–98.
45. Lemieux S, Prud'homme D, Bouchard C, Tremblay A, Despres JP. Sex differences in the relation of visceral adipose tissue accumulation to total body fatness. Am J Clin Nutr 1993; 58(4):463–467.
46. Couillard C, Bergeron N, Prud'homme D, Bergeron J, Tremblay A, Bouchard C, Mauriege P, Despres JP. Gender difference in postprandial lipemia: importance of visceral adipose tissue accumulation. Arterioscler Thromb Vasc Biol 1999; 19(10):2448–2455.
47. Kelley DE, Williams KV, Price JC, McKolanis TM, Goodpaster BH, Thaete FL. Plasma Fatty acids, adiposity, and variance of skeletal muscle insulin resistance in type 2 diabetes mellitus. J Clin Endocrinol Metab 2001; 86(11):5412–5419.
48. Hill JO, Sidney S, Lewis CE, Tolan K, Scherzinger AL, Stamm ER. Racial differences in amounts of visceral adipose tissue in young adults:The CARDIA (Coronary Artery Risk Development in Young Adults) study. Am J Clin Nutr 1999; 69(3):381–387.
49. Conway JM, Yanovski SZ, Avila NA, Hubbard VS. Visceral adipose tissue differences in black and white women. Am J Clin Nutr 1995; 61(4):765–771.
50. Albu JB, Murphy L, Frager DH, Johnson JA, Pi-Sunyer FX. Visceral fat and race-dependent health risks in obese nondiabetic premenopausal women. Diabetes 1997; 46(3):456–462.
51. Goran MI, Bergman RN, Gower BA. Influence of total vs. visceral fat on insulin action and secretion in African American and white children. Obes Res 2001; 9(8):423–431.
52. Goran MI, Nagy TR, Treuth MS, Trowbridge C, Dezenberg C, McGloin A. Visceral fat in white and African American prepubertal children. Am J Clin Nutr 1997; 65(6):1703–1708.
53. Park YW, Allison DB, Heymsfield SB, Gallagher D. Larger amounts of visceral adipose tissue in Asian Americans. Obes Res 2001; 9(7):381–387.
54. Takahashi K, Hata J, Mukai K, Sawasaki Y. Close similarity between cultured human omental mesothe-lial cells and endothelial cells in cytochemical markers and plasminogen activator production. In Vitro Cell Dev Biol 1991; 27A(7):542–548.
55. Chung-Welch N, Patton WF, Shepro D, Cambria RP. Two-stage isolation procedure for obtaining homogenous populations of microvascular endothelial and mesothelial cells from human omentum. Microvasc Res 1997; 54(2):121–134.
56. Chung-Welch N, Patton WF, Shepro D, Cambria RP. Human omental microvascular endothelial and mesothelial cells: characterization of two distinct mesodermally derived epithelial cells. Microvasc Res 1997; 54(2):108–120.
57. Bornstein SR, Abu-Asab M, Glasow A, Path G, Hauner H, Tsokos M, Chrousos GP, Scherbaum WA. Immunohistochemical and ultrastructural localization of leptin and leptin receptor in human white adipose tissue and differentiating human adipose cells in primary culture. Diabetes 2000; 49(4):532–538.
58. Mattacks CA, Pond CM. Interactions of noradrenalin and tumour necrosis factor alpha, interleukin 4 and interleukin 6 in the control of lipolysis from adipocytes around lymph nodes. Cytokine 1999; 11(5): 334–346.
59. Adams M, Montague CT, Prins JB, Holder JC, Smith SA, Sanders L, Digby JE, Sewter CP, Lazar MA, Chatterjee VK, O'Rahilly S. Activators of peroxisome proliferator-activated receptor gamma have depot-specific effects on human preadipocyte differentiation. J Clin Invest 1997; 100(12):3149–3153.
60. Hube F, Lee YM, Rohrig K, Hauner H. The phosphodiesterase inhibitor IBMX suppresses TNF-alpha expression in human adipocyte precursor cells: a possible explanation for its adipogenic effect. Horm Metab Res 1999; 31(6):359–362.
61. Path G, Bornstein SR, Gurniak M, Chrousos GP, Scherbaum WA, Hauner H. Human breast adipocytes express interleukin-6 (IL-6) and its receptor system: increased IL-6 production by beta-adrenergic activation and effects of IL-6 on adipocyte function. J Clin Endocrinol Metab 2001; 86(5):2281–2288.
62. Fried SK, Bunkin DA, Greenberg AS. Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: deot difference and regulation by glucocorticoid. J Clin Endocrinol Metab 1998; 83:847–850.
63. van HV, Reynisdottir S, Eriksson P, Thorne A, Hoffstedt J, Lönnqvist F, Arner P. Leptin secretion from subcutaneous and visceral adipose tissue in women. Diabetes 1998; 47(6):913–917.
64. Reynisdottir S, Dauzats M, Thorne A, Langin D. Comparison of hormone-sensitive lipase activity in visceral and subcutaneous human adipose tissue. J Clin Endocrinol Metab 1997; 82(12):4162–4166.
65. Rebuffe-Scrive M, Andersson B, Olbe L, Björntorp P. Metabolism of adipose tissue in intraabdominal depots of nonobese men and women. Metabolism 1989; 38:453–458.
66. Hoffstedt J, Arner P, Hellers G, Lönnqvist F. Variation in adrenergic regulation of lipolysis between omental and subcutaneous adipocytes from obese and non-obese men. J Lipid Res 1997; 38(4):795–804.
67. Rebuffe-Scrive M, Anderson B, Olbe L, Björntorp P. Metabolism of adipose tissue in intraabdominal depots in severely obese men and women. Metabolism 1990; 39(10):1021–1025.
68. Fried SK, Russell CD, Grauso NL, Brolin RE. Lipoprotein lipase regulation by insulin and glucocorticoid in subcutaneous and omental adipose tissues of obese women and men. J Clin Invest 1993; 92(5): 2191–2198.
69. Fried SK, Kral JG. Sex differences in regional distribution of fat cell size and lipoprotein lipase activity in morbidly obese patients. Int J Obes 1987; 11(2): 129–140.
70. van HV, Lönnqvist F, Thorne A, Wennlund A, Large V, Reynisdottir S, Arner P. Noradrenaline-induced lipolysis in isolated mesenteric, omental and subcutaneous adipocytes from obese subjects. Int J Obes Relat Metab Disord 1997; 21(11):972–979.
71. Marette A, Mauriege P, Marcotte B, Atgie C, Bouchard C, Theriault G, Bukowiecki LJ, Marceau P, Biron S, Nadeau A, Despres JP. Regional variation in adipose tissue insulin action and GLUT4 glucose transporter expression in severely obese premenopausal women. Diabetologia 1997; 40(5):590–598.
72. Mauriege P, Marette A, Atgie C, Bouchard C, Theriault G, Bukowiecki LK, Marceau P, Biron S, Nadeau A, Despres JP. Regional variation in adipose tissue metabolism of severely obese premenopausal women. J Lipid Res 1995; 36(4):672–684.
73. Fried SK, Leibel RL, Edens NK, Kral JG. Lipolysis in intraabdominal adipose tissues of obese women and men. Obes Res 1993; 1:443–448.
74. Hellmer J, Marcus C, Sonnenfeld T, Arner P. Mechanisms for differences in lipolysis between human subcutaneous and omental fat cells. J Clin Endocrinol Metab 1992; 75(1):15–20.
75. Rebuffe-Scrive M, Andersson B, Olbe L, Björntorp P. Metabolism of adipose tissue in intraabdominal depots of nonobese men and women. Metabolism 1989; 38(5): 453–458.
76. Vikman HL, Ranta S, Kiviluoto T, Ohisalo JJ. Different metabolic regulation by adenosine in omental and subcutaneous adipose tissue. Acta Physiol Scand 1991; 142(3):405–410.
77. Edens NK, Fried SK, Kral JG, Hirsch J, Leibel RL. In vitro lipid synthesis in human adipose tissue from three abdominal sites. Am J Physiol 1993; 265(3 Pt 1): E374-E379.
78. Ryden M, Elizalde M, Ohlund A, Hoffstedt J, Bringman S, Andersson K. Increased expression of eNOS protein in omental versus subcutaneous adipose tissue in obese human subjects. Int J Obes Relat Metab Disord 2001; 25(6):811–815.
79. Lönnqvist F, Thorne A, Large V, Arner P. Sex differences in visceral fat lipolysis and metabolic complications of obesity. Arterioscler Thromb Vasc Biol 1997; 17(7):1472–1480.
80. Mauriege P, Galitzky J, Berlan M, Lafontan M. Heterogeneous distribution of beta and alpha-2 adrenoceptor binding sites in human fat cells from various fat deposits: functional consequences. Eur J Clin Invest 1987; 17:156–165.
81. Zierath JR, Livingston JN, Thorne A, Bolinder J, Reynisdottir S, Lönnqvist F, Arner P. Regional difference in insulin inhibition of non-esterified fatty acid release from human adipocytes: relation to insulin receptor phosphorylation and intracellular signalling through the insulin receptor substrate-1 pathway. Dia-betologia 1998; 41(11):1343–1354.
82. Meek SE, Nair KS, Jensen MD. Insulin regulation of regional free fatty acid metabolism. Diabetes 1999; 48(1):10–14.
83. Basu A, Basu R, Shah P, Vella A, Rizza RA, Jensen MD. Systemic and regional free fatty acid metabolism in type 2 diabetes. Am J Physiol Endocrinol Metab 2001; 280(6):E1000-E1006.
84. Guo Z, Johnson CM, Jensen MD. Regional lipolytic responses to isoproterenol in women. Am J Physiol 1997; 273(1 Pt 1):E108-E112.
85. Marin P, Lönn L, Andersson B, Oden B, Olbe L, Bengtsson BA, Björntorp P. Assimilation of triglycerides in subcutaneous and intraabdominal adipose tissues in vivo in men: effects of testosterone. J Clin Endocrinol Metab 1996; 81(3):1018–1022.
86. Lefebvre AM, Laville M, Vega N, Riou JP, van Gaal L, Auwerx J, Vidal H. Depot-specific differences in adipose tissue gene expression in lean and obese subjects. Diabetes 1998; 47(1):98–103.
87. Maslowska MH, Sniderman AD, Maclean LD, Cian-flone K. Regional differences in triacylglycerol synthesis in adipose tissue and in cultured preadipocytes. J Lipid Res 1993; 34:219–227.
88. Saleh J, Christou N, Cianflone K. Regional specificity of ASP binding in human adipose tissue. Am J Physiol 1999; 276(5 Pt 1):E815-E821.
89. Montague CT, Prins JB, Sanders L, Zhang J, Sewter CP, Digby J, Byrne CD, O'Rahilly S. Depot-related gene expression in human subcutaneous and omental adipocytes. Diabetes 1998; 47(9):1384–1391.
90. Panarotto D, Poisson J, Devroede G, Maheux P. Lipoprotein lipase steady-state mRNA levels are lower in human omental versus subcutaneous abdominal adipose tissue. Metabolism 2000; 49(9):1224–1227.
91. Pedersen SB, Jonler M, Richelsen B. Characterization of regional and gender differences in glucocorticoid receptors and lipoprotein lipase activity in human adipose tissue. J Clin Endocrinol Metab 1994; 78(6): 1354–1359.
92. Frayn KN, Coppack SW, Fielding BA, Humphreys SM. Coordinated regulation of hormone-sensitive lipase and lipoprotein lipase in human adipose tissue in vivo: implications for the control of fat storage and fat mobilization. Adv Enzyme Regul 1995; 35:163–178.
93. Kolehmainen M, Vidal H, Alhava E, Uusitupa MI. Sterol regulatory element binding protein 1c (SREBP-1c) expression in human obesity. Obes Res 2001; 9(11): 706–712.
94. Ribot J, Rantala M, Kesaniemi YA, Palou A, Savolai-nen MJ. Weight loss reduces expression of SREBP1c/ADD1 and PPARgamma2 in adipose tissue of obese women. Pflugers Arch 2001; 441(4):498–505.
95. Caserta F, Tchkonia T, Civelek VN, Prentki M, Brown NF, McGarry JD. Fat depot origin affects fatty acid handling in cultured rat and human preadipocytes. Am J Physiol Endocrinol Metab 2001; 280(2): E238-E247.
96. Fisher RM, Eriksson P, Hoffstedt J, Hotamisligil GS, Thorne A, Ryden M. Fatty acid binding protein expression in different adipose tissue depots from lean and obese individuals. Diabetologia 2001; 44(10): 1268–1273.
97. Hotamisligil GS, Johnson RS, Distel RJ, Ellis R, Papaioannou VE, Spiegelman BM. Uncoupling of obesity from insulin resistance through a targeted mutation in aP2, the adipocyte fatty acid binding protein. Science 1996; 274(5291):1377–1379.
98. Uysal KT, Scheja L, Wiesbrock SM, Bonner-Weir S, Hotamisligil GS. Improved glucose and lipid metabolism in genetically obese mice lacking aP2. Endocrinology 2000; 141(9):3388–3396.
99. Shaughnessy S, Smith ER, Kodukula S, Storch J, Fried SK. Adipocyte metabolism in adipocyte fatty acid binding protein knockout mice (aP2-/-) after shortterm high-fat feeding: functional compensation by the keratinocyte fatty acid binding protein. Diabetes 2000; 49(6):904–911.
100. Schoen RE, Evans RW, Sankey SS, Weissfeld JL, Kuller L. Does visceral adipose tissue differ from subcutaneous adipose tissue in fatty acid content? Int J Obes Relat Metab Disord 1996; 20(4):346–352.
101. Digby JE, Crowley VE, Sewter CP, Whitehead JP, Prins JB, O'Rahilly S. Depot-related and thiazolidi-nedione-responsive expression of uncoupling protein 2 (UCP2) in human adipocytes. Int J Obes Relat Metab Disord 2000; 24(5):585–592.
102. West DB, Prinz WA, Greenwood MR. Regional changes in adipose tissue blood flow and metabolism in rats after a meal. Am J Physiol 1989; 257(4 Pt 2): R711-R716.
103. Crandall DL, Goldstein BM, Huggins F, Cervoni P. Adipocyte blood flow: influence of age, anatomic location, and dietary manipulation. Am J Physiol 1984; 247(1 Pt 2):R46-R51.
104. Bartness TJ, Bamshad M. Innervation of mammalian white adipose tissue: implications for the regulation of total body fat. Am J Physiol 1998; 275(5 Pt 2):R1399-R1411.
105. Rebuffe-Scrive M. Neuroregulation of adipose tissue: molecular and hormonal mechanims. Int J Obes Relat Metab Disord 1991; 15:83–86.
106. Elbers JM, Asscheman H, Seidell JC, Gooren LJ. Effects of sex steroid hormones on regional fat depots as assessed by magnetic resonance imaging in transsexuals. Am J Physiol 1999; 276(2 Pt 1):E317-E325.
107. Elbers JM, Asscheman H, Seidell JC, Megens JA, Gooren LJ. Long-term testosterone administration increases visceral fat in female to male transsexuals. J Clin Endocrinol Metab 1997; 82(7):2044–2047.
108. Seidell JC, Björntorp P, Sjöström L., Kvist H, Sannerstedt R. Visceral fat accumulation in men is positively associated with insulin, glucose, and C-peptide levels, but negatively with testosterone levels. Metabolism 1990; 39(9):897–901.
109. Tchernof A, Labrie F, Belanger A, Prud'homme D, Bouchard C, Tremblay A, Nadeau A, Despres JP. Relationships between endogenous steroid hormone, sex hormone-binding globulin and lipoprotein levels in men: contribution of visceral obesity, insulin levels and other metabolic variables. Atherosclerosis 1997; 133(2):235–244.
110. Anderson LA, McTernan PG, Barnett AH, Kumar S. The effects of androgens and estrogens on preadipocyte proliferation in human adipose tissue: influence of gender and site. J Clin Endocrinol Metab 2001; 86(10): 5045–5051.
111. Roncari DA, Van RL. Promotion of human adipocyte precursor replication by 17beta-estradiol in culture. J Clin Invest 1978; 62(3):503–508.
112. Pecquery R, Dieudonne MN, Cloix JF, Leneveu MC, Dausse JP, Giudicelli Y. Enhancement of the expression of the alpha 2-adrenoreceptor protein and mRNA by a direct effect of androgens in white adipocytes. Biochem Biophys Res Commun 1995; 206(1): 112–118.
113. Bouloumié A, Valet P, Dauzats M, Lafontan M, Saulnier-Blache JS. In vivo upregulation of adipocyte alpha 2-adrenoceptors by androgens is consequence of direct action on fat cells. Am J Physiol 1994; 267(4 Pt 1):C926-C931.
114. Giudicelli Y, Dieudonne MN, Lacasa D, Pasquier YN, Pecquery R. Modulation by sex hormones of the membranous transducing system regulating fatty acid mobilization in adipose tissue. Prostaglandins Leukot Essent Fatty Acids 1993; 48(1):91–100.
115. Xu XF, De Pergola G, Björntorp P. Testosterone increases lipolysis and the number of beta-adreno-ceptors in male rat adipocytes. Endocrinology 1991; 128(1): 379–382.
116. Pedersen SB, Bruun JM, Hube F, Kristensen K, Hauner H, Richelsen B. Demonstration of estrogen receptor subtypes alpha and beta in human adipose tissue: influences of adipose cell differentiation and fat depot localization. Mol Cell Endocrinol 2001; 182(1): 27–37.
117. Lo JC, Mulligan K, Noor MA, Schwarz JM, Halvorsen RA, Grunfeld C, Schambelan M. The effects of recombinant human growth hormone on body composition and glucose metabolism in HIV-infected patients with fat accumulation. J Clin Endocrinol Metab 2001; 86(8):3480–3487.
118. Roemmich JN, Huerta MG, Sundaresan SM, Rogol AD. Alterations in body composition and fat distribution in growth hormone-deficient prepubertal children during growth hormone therapy. Metabolism 2001; 50(5):537–547.
119. Brummer RJ. Effects of growth hormone treatment on visceral adipose tissue. Growth Horm IGF Res 1998; 8(suppl B):19–23.
120. Nam SY, Kim KR, Cha BS, Song YD, Lim SK, Lee HC, Huh KB. Low-dose growth hormone treatment combined with diet restriction decreases insulin resistance by reducing visceral fat and increasing muscle mass in obese type 2 diabetic patients. Int J Obes Relat Metab Disord 2001; 25(8):1101–1107.
121. Johannsson G, Marin P, Lönn L, Ottosson M, Stenlof K, Björntorp P, Sjöström L., Bengtsson BA. Growth hormone treatment of abdominally obese men reduces abdominal fat mass, improves glucose and lipoprotein metabolism, and reduces diastolic blood pressure. J Clin Endocrinol Metab 1997; 82(3):727–734.
122. Ottosson M, Vikman-Adolfsson K, Enerbäck S, Olivecrona G, Björntorp P. The effects of cortisol on the regulation of lipoprotein lipase activity in human adipose tissue. J Clin Endocrinol Metab 1994; 79(3): 820–825.
123. Lönn L, Kvist H, Ernest I, Sjöström L. Changes in body composition and adipose tissue distribution after treatment of women with Cushing's syndrome. Metabolism 1994; 43(12):1517–1522.
124. Joyner JM, Hutley LJ, Cameron DP. Glucocorticoid receptors in human preadipocytes: regional and gender differences. J Endocrinol 2000; 166(1):145–152.
125. Miller LK, Kral JG, Strain GW, Zumoff B. Differ ential binding of dexamethasone to ammonium sulfate precipitates of human adipose tissue cytosols. Steroids 1987; 49(6):507–522.
126. Rebuffe-Scrive M, Lundholm K, Björntorp P. Glucocorticoid hormone binding to human adipose tissue. Eur J Clin Invest 1985; 15(5):267–271.
127. Sjögren J, Weck M, Nilsson A, Ottosson M, Björntorp P. Glucocorticoid hormone binding to rat adipocytes. Biochim Biophys Acta 1994; 1224(1):17–21.
128. Russell CD, Petersen RN, Rao SP, Ricci MR, Prasad 142, A, Zhang Y, Brolin RE, Fried SK. Leptin expression in adipose tissue from obese humans: depot-specific regulation by insulin and dexamethasone. Am J Phys-143 iol 1998; 275(3 Pt 1):E507-E515.
129. Bujalska IJ, Kumar S, Stewart PM. Does central obesity reflect “Cushing's disease of the omentum”? Lancet 1997; 349(9060):1210–1213.
130. Bujalska IJ, Kumar S, Hewison M, Stewart PM. Differentiation of adipose stromal cells: the roles of glucocorticoids and 11 beta-hydroxysteroid dehydrogenase. Endocrinology 1999; 140(7):3188–3196.
131. Katzmarzyk PT, Malina RM, Perusse L, Rice T, Province MA, Rao DC, Bouchard C. Familial re-145 semblance in fatness and fat distribution. Am J Human Biol 2000; 12(3):395–404.
132. Rosmond R, Chagnon M, Bouchard C, Björntorp P. A missense mutation in the human melanocortin-4 receptor gene in relation to abdominal obesity and 146 salivary cortisol. Diabetologia 2001; 44(10):1335–1338.
133. Rosmond R, Chagnon YC, Chagnon M, Perusse L, Bouchard C, Björntorp P. A polymorphism of the 5'-flanking region of the glucocorticoid receptor gene locus is associated with basal cortisol secretion in men. Metabolism 2000; 49(9):1197–1199.
134. Rosmond R, Bouchard C, Björntorp P. Tsp509l polymorphism in exon 2 of the glucocorticoid receptor gene in relation to obesity and cortisol secretion: cohort study. BMJ 2001; 322(7287):652–653.
135. Nakamura T, Funahashi T, Yamashita S, Nishida M, Nishida Y, Takahashi M. Thiazolidinedione derivative improves fat distribution and multiple risk factors in subjects with visceral fat accumulation-double-blind placebo-controlled trial. Diabetes Res Clin Pract 2001; 54(3):181–190.
136. Kelly IE, Han TS, Walsh K, Lean ME. Effects of a thiazolidinedione compound on body fat and fat distribution of patients with type 2 diabetes. Diabetes Care 1999; 22(2):288–293.
137. De Souza CJ, Eckhardt M, Gagen K, Dong M, Chen W, Laurent D. Effects of pioglitazone on adipose tissue remodeling within the setting of obesity and insulin resistance. Diabetes 2001; 50(8):1863–1871.
138. Ahima RS, Flier JS. Adipose tissue as an endocrine organ. Trends Endocrinol Metab 2000; 11(8):327–332.
139. Ricci MR, Fried SK. Isoproterenol decreases leptin expression in adipose tissue of obese humans. Obes Res 1999; 7(3):233–240.
140. Arner P. Differences in lipolysis between human subcutaneous and omental adipose tissues. Ann Med 1995; 27(4):435–438.
141. Montague CT, Prins JB, Sanders L, Digby JE, O'Rahilly S. Depot-and sex-specific differences in human leptin mRNA expression: implications for the control of regional fat distribution. Diabetes 1997; 46(3):342–347.
142. Frayn KN. Visceral fat and insulin resistance-causative or correlative? Br J Nutr 2000; 83(suppl 1):S71-S77.
143. Mohamed-Ali V, Goodrick S, Rawesh A, Katz DR, Miles JM, Yudkin JS, Klein S, Coppack SW. Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-αlpha, in vivo. J Clin Endocrinol Metab 1997; 82(12):4196–4200.
144. Kern PA, Ranganathan S, Li C, Wood L, Ranganathan G. Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. Am J Physiol Endocrinol Metab 2001; 280(5):E745-E751.
145. Bastard JP, Jardel C, Bruckert E, Blondy P, Capeau J, Laville M, Vidal H, Hainque B. Elevated levels of interleukin 6 are reduced in serum and subcutaneous adipose tissue of obese women after weight loss. J Clin Endocrinol Metab 2000; 85(9):3338–3342.
146. Mohamed-Ali V, Bulmer K, Clarke D, Goodrick S, Coppack SW, Pinkney JH. Beta-adrenergic regulation of proinflammatory cytokines in humans. Int J Obes Relat Metab Disord 2000; 24(suppl 2):S154-S155.
147. Orban Z, Remaley AT, Sampson M, Trajanoski Z, Chrousos GP. The differential effect of food intake and beta-adrenergic stimulation on adipose-derived hormones and cytokines in man. J Clin Endocrinol Metab 1999; 84(6):2126–2133.
148. McCarty MF. Interleukin-6 as a central mediator of cardiovascular risk associated with chronic inflammation, smoking, diabetes, and visceral obesity: down-regulation with essential fatty acids, ethanol and pentoxifylline. Med Hypotheses 1999; 52(5):465–477.
149. Vozarova B, Weyer C, Hanson K, Tataranni PA, Bogardus C, Pratley RE. Circulating interleukin-6 in relation to adiposity, insulin action, and insulin secretion. Obes Res 2001; 9(7):414–417.
150. Forouhi NG, Sattar N, McKeigue PM. Relation of C-reactive protein to body fat distribution and features of the metabolic syndrome in Europeans and South Asians. Int J Obes Relat Metab Disord 2001; 25(9): 1327–1331.
151. Mohamed-Ali H, Pinkney JH, Coppack SW. Adipose tissue as an endocrine and paracrine organ. Int J Obes 1998; 22(12):1145–1158.
152. Gerhardt CC, Romero IA, Cancello R, Camoin L, Strosberg AD. Chemokines control fat accumulation and leptin secretion by cultured human adipocytes. Mol Cell Endocrinol 2001; 175(1-2):81–92.
153. Coppack SW. Pro-inflammatory cytokines and adipose tissue. Proc Nutr Soc 2001; 60(3):349–356.
154. Bruun JM, Pedersen SB, Richelsen B. Interleukin-8 production in human adipose tissue. inhibitory effects of anti-diabetic compounds, the thiazolidinedione ciglitazone and the biguanide metformin. Horm Metab Res 2000; 32(11-12):537–541.
155. Bruun JM, Pedersen SB, Richelsen B. Regulation of interleukin 8 production and gene expression in human adipose tissue in vitro. J Clin Endocrinol Metab 2001; 86(3):1267–1273.
156. Zhang HH, Kumar S, Barnett AH, Eggo MC. Intrinsic site-specific differences in the expression of leptin in human adipocytes and its autocrine effects on glucose uptake. J Clin Endocrinol Metab 1999; 84(7): 2550–2556.
157. Niesler CU, Prins JB, O'Rahilly S, Siddle K, Montague CT. Adipose depot-specific expression of cIAP2 in human preadipocytes and modulation of expression by serum factors and TNFalpha. Int J Obes Relat Metab Disord 2001; 25(7):1027–1033.
158. Yamauchi T, Kamon J, Waki H, Terauchi Y, Kubota N, Hara K, Mori Y, Ide T, Murakami K, Tsuboyama-Kasaoka N, Ezaki O, Akanuma Y, Gavrilova O, Vinson C, Reitman ML, Kagechika H, Shudo K, Yoda M, Nakano Y, Tobe K, Nagai R, Kimura S, Tomita M, Froguel P, Kadowaki T. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 2001; 7(8):941–946.
159. Berg AH, Combs TP, Du X, Brownlee M, Scherer PE. The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nat Med 2001; 7(8):947–953.
160. Combs TP, Berg AH, Obici S, Scherer PE, Rossetti L. Endogenous glucose production is inhibited by the adipose-derived protein Acrp30. J Clin Invest 2001; 108(12):1875–1881.
161. Statnick MA, Beavers LS, Conner LJ, Corominola H, Johnson D, Hammond CD, Rafaeloff-Phail R, Seng T, Suter TM, Sluka JP, Ravussin E, Gadski RA, Caro JF. Decreased expression of apM1 in omental and subcutaneous adipose tissue of humans with type 2 diabetes. Int J Exp Diabetes Res 2000; 1(2): 81–88.
162. Singh A, Purohit A, Ghilchik MW, Reed MJ. The regulation of aromatase activity in breast fibroblasts: the role of interleukin-6 and prostaglandin E2. Endocr Relat Cancer 1999; 6(2):139–147.
163. Cooke PS, Heine PA, Taylor JA, Lubahn DB. The role of estrogen and estrogen receptor-alpha in male adipose tissue. Mol Cell Endocrinol 2001; 178(1-2): 147–154.
164. Heine PA, Taylor JA, Iwamoto GA, Lubahn DB, Cooke PS. Increased adipose tissue in male and female estrogen receptor-alpha knockout mice. Proc Natl Acad Sci USA 2000; 97(23):12729–12734.
165. Anwar A, McTernan PG, Anderson LA, Askaa J, Moody CG, Barnett AH, Eggo MC, Kumar S. Site-specific regulation of oestrogen receptor-alpha and -beta by oestradiol in human adipose tissue. Diabetes Obes Metab 2001; 3(5):338–349.
166. Napolitano A, Voice MW, Edwards CR, Seckl JR, Chapman KE. 11Beta-hydroxysteroid dehydrogenase 1 in adipocytes: expression is differentiation-dependent and hormonally regulated. J Steroid Biochem Mol Biol 1998; 64(5-6):251–260.
167. Ricketts ML, Verhaeg JM, Bujalska I, Howie AJ, Rainey WE, Stewart PM. Immunohistochemical localization of type 1 11beta-hydroxysteroid dehydrogenase in human tissues. J Clin Endocrinol Metab 1998; 83(4):1325–1335.
168. Tomlinson JW, Bujalska I, Stewart PM, Cooper MS. The role of 11beta-hydroxysteroid dehydrogenase in central obesity and osteoporosis. Endocr Res 2000; 26(4):711–722.
169. Tomlinson JW, Moore J, Cooper MS, Bujalska I, Shahmanesh M, Burt C, Strain A, Hewison M, Stewart PM. Regulation of expression of 11beta-hydroxysteroid dehydrogenase type 1 in adipose tissue: tissue-specific induction by cytokines. Endocrinology 2001; 142(5):1982–1989.
170. Katz JR, Mohamed-Ali V, Wood PJ, Yudkin JS, Coppack SW. An in vivo study of the cortisol-cortisone shuttle in subcutaneous abdominal adipose tissue. Clin Endocrinol (Oxf) 1999; 50(1):63–68.
171. Rask E, Olsson T, Soderberg S, Andrew R, Livingstone DEW, Johnson O, Walker BR. Tissue-specific dysregulation of cortisol metabolism in human obesity. J Clin Endocrinol Metab 2001; 86:1418–1421.
172. Dusserre E, Moulin P, Vidal H. Differences in mRNA expression of the proteins secreted by the adipocytes in human subcutaneous and visceral adipose tissues. Bio-chim Biophys Acta 2000; 1500(1):88–96.
173. Giacchetti G, Faloia E, Sardu C, Camilloni MA, Mariniello B, Gatti C, Garrapa GG, Guerrieri M, Mantero F. Gene expression of angiotensinogen in adipose tissue of obese patients. Int J Obes Relat Metab Disord 2000; 24(suppl 2):S142-S143.
174. Fried SK, Russell CD. Diverse roles of the adipose tissue in the regulation of systemic metabolism and energy balance. In: Bray GA, Bouchard C, James WPT eds. Handbook of Obesity. New York: Marcel Dekker, 1998:397–413.
175. Seki T, Miyasu T, Noguchi T, Hamasaki A, Sasaki R, Ozawa Y, Okukita K, Declerck PJ, Ariga T. Reciprocal regulation of tissue-type and urokinase-type plasminogen activators in the differentiation of murine preadipocyte line 3T3-L1 and the hormonal regulation of fibrinolytic factors in the mature adipocytes. J Cell Physiol 2001; 189(1):72–78.
176. Giltay EJ, Elbers JM, Gooren LJ, Emeis JJ, Kooistra T, Asscheman H. Stehouwer CD Visceral fat accumulation is an important determinant of PAI-1 levels in young, nonobese men and women: modulation by cross-sex hormone administration. Arterioscler Thromb Vasc Biol 1998; 18(11):1716–1722.
177. Gottschling-Zeller H, Birgel M, Rohrig K, Hauner H. Effect of tumor necrosis factor alpha and transforming growth factor beta 1 on plasminogen activator inhibitor-1 secretion from subcutaneous and omental human fat cells in suspension culture. Metabolism 2000; 49(5):666–671.
178. Eriksson P, van HV, Hoffstedt J, Lundquist P, Vidal H, Stemme V, Hamsten A, Arner P, Reynisdottir S. Regional variation in plasminogen activator inhibitor-1 expression in adipose tissue from obese individuals. Thromb Haemost 2000; 83(4):545–548.
179. Alessi MC, Peiretti F, Morange P, Henry M, Nalbone G, Juhan-Vague I. Production of plasminogen activator inhibitor 1 by human adipose tissue: possible link between visceral fat accumulation and vascular disease. Diabetes 1997; 46(5):860–867.
180. Polac I, Cierniewska-Cieslak A, Stachowiak G, Pertynski T, Cierniewski CS. Similar PAI-1 expression in visceral and subcutaneous fat of postmenopausal women. Thromb Res 2001; 102(5):397–405.
181. Crandall DL, Quinet EM, Morgan GA, Busler DE, McHendry-Rinde B, Kral JG. Synthesis and secretion of plasminogen activator inhibitor-1 by human preadipocytes. J Clin Endocrinol Metab 1999; 84(9): 3222–3227.
182. Yudkin JS, Coppack SW, Bulmer K, Rawesh A, Mohamed-Ali V. Lack of evidence for secretion of plasminogen activator inhibitor-1 by human subcutaneous adipose tissue in vivo. Thromb Res 1999; 96(1): 1–9.
183. Crandall DL, Busler DE, McHendry-Rinde B, Groel-ing TM, Kral JG. Autocrine regulation of human preadipocyte migration by plasminogen activator inhibitor-1. J Clin Endocrinol Metab 2000; 85(7):2609–2614.
184. Schafer K, Fujisawa K, Konstantinides S, Loskutoff DJ. Disruption of the plasminogen activator inhibitor 1 gene reduces the adiposity and improves the metabolic profile of genetically obese and diabetic ob/ob mice. FASEB J 2001; 15(10):1840–1842.
185. Garg A. Lipodystrophies. Am J Med 2000; 108(2): 143–152.
186. Engelson ES, Kotler DP, Tan Y, Agin D, Wang J, Pierson RN Jr, Heymsfield SB. Fat distribution in HIV-infected patients reporting truncal enlargement quantified by whole-body magnetic resonance imaging. Am J Clin Nutr 1999; 69(6):1162–1169.
187. Esterbauer H, Krempler F, Oberkofler H, Patsch W. The complement system: a pathway linking host defence and adipocyte biology. Eur J Clin Invest 1999; 29(8):653–656.
188. Choy LN, Rosen BS, Spiegelman BM. Adipsin and an endogenous pathway of complement from adipose cells. J Biol Chem 1992; 267(18):12736–12741.
189. Ross R, Fortier L, Hudson R. Separate associations between visceral and subcutaneous adipose tissue distribution, insulin and glucose levels in obese women. Diabetes Care 1996; 19(12):1404–1411.
190. Pare A, Dumont M, Lemieux I, Brochu M, Almeras N, Lemieux S, Prud'homme D, Despres JP. Is the relationship between adipose tissue and waist girth altered by weight loss in obese men? Obes Res 2001; 9(9):526–534.
191. Ross R, Janssen I. Is abdominal fat preferentially reduced in response to exercise-induced weight loss? Med Sci Sports Exerc 1999; 31(11 suppl):S568-S572.
192. Ross R, Janssen I, Stallknecht B. Influence of endurance exercise on adipose tissue distribution. In: Nicklas B,. Endurance Exercise and Adipose Tissue Boca Raton, FL: CRC Press, 2001:122–152.
193. Ross R, Janssen I. Physical activity, total and regional obesity: dose-response considerations. Med Sci Sports Exerc 2001; 33(6 suppl):S521-S527.
194. Ross R, Dagnone D, Jones PJ, Smith H, Paddags A, Hudson R, Janssen I. Reduction in obesity and related comorbid conditions after diet-induced weight loss or exercise-induced weight loss in men. A randomized, controlled trial. Ann Intern Med 2000; 133(2): 92–103.
195. Mourier A, Gautier JF, De Kerviler E, Bigard AX, Villette JM, Garnier JP, Duvallet A, Guezennec CY, Cathelineau G. Mobilization of visceral adipose tissue related to the improvement in insulin sensitivity in response to physical training in NIDDM, Effects of branched-chain amino acid supplements. Diabetes Care 1997; 20(3):385–391.
196. Thomas EL, Brynes AE, McCarthy J, Goldstone AP, Hajnal JV, Saeed N, Frost G, Bell JD. Preferential loss of visceral fat following aerobic exercise, measured by magnetic resonance imaging. Lipids 2000; 35(7):769–776.
197. Poehlman ET, Dvorak RV, DeNino WF, Brochu M, Ades PA. Effects of resistance training and endurance training on insulin sensitivity in nonobese, young women: a controlled randomized trial. J Clin Endocrinol Metab 2000; 85(7):2463–2468.
198. DiPietro L, Seeman TE, Stachenfeld NS, Katz LD, Nadel ER. Moderate-intensity aerobic training improves glucose tolerance in aging independent of abdominal adiposity. J Am Geriatr Soc 1998; 46(7): 875–879.
199. Despres JP, Lamarche B. Effects of diet and physical activity on adiposity and body fat distribution: implications for the prevention of cardiovascular disease. Nutr Res Rev 1999; 6:137–159.
200. Williams MJ, Hunter GR, Kekes-Szabo T, Trueth MS, Snyder S, Berland L, Blaudeau T. Intra-abdominal adipose tissue cut-points related to elevated cardiovascular risk in women. Int J Obes Relat Metab Disord 1996; 20(7):613–617.
201. Schwartz RS, Shuman WP, Larson V, Cain KC, Fellingham GW, Beard JC, Kahn SE, Stratton JR, Cerqueira MD, Abrass IB. The effect of intensive endurance exercise training on body fat distribution in young and oldermen. Metabolism 1991; 40(5):545–551.
202. Wilmore JH, Despres JP, Stanforth PR, Mandel S, Rice T, Gagnon J, Leon AS, Rao D, Skinner JS, Bouchard C. Alterations in body weight and composition consequent to 20 wk of endurance training: the HERITAGE Family Study. Am J Clin Nutr 1999; 70(3):346–352.
203. Bouchard C, Tremblay A, Despres JP. The response to exercise with constant energy intake in identical twins. Obes Res 1994; 2:400–410.
204. Glazer G. Long-term pharmacotherapy of obesity 2000: a review of efficacy and safety. Arch Intern Med 2001; 161(15):1814–1824.
205. Van Gaal LF, Wauters MA, Peiffer FW, De Leeuw IH. Sibutramine and fat distribution: is there a role for pharmacotherapy in abdominal/visceral fat reduction? Int J Obes Relat Metab Disord 1998; 22(suppl 1):S38-S40.
206. Marcus MA, Murphy L, Pi-Sunyer FX, Albu JB. Insulin sensitivity and serum triglyceride level in obese white and black women: relationship to visceral and truncal subcutaneous fat. Metabolism 1999; 48(2): 194–199.
207. Albu JB, Curi M, Shur M, Murphy L, Matthews DE, Pi-Sunyer FX. Systemic resistance to the antilipolytic effect of insulin in black and white women with visceral obesity. Am J Physiol 1999; 277(3 Pt 1):E551-E560.
208. Seidell J, Bouchard C. Visceral fat in relation to health: is it a major culprit or simply an innocent bystander? Int J Obes 1997;21:626–631.
209. Goodpaster BH, Thaete FL, Simoneau JA, Kelley DE. Subcutaneous abdominal fat and thigh muscle composition predict insulin sensitivity independently of visceral fat. Diabetes 1997; 46(10):1579–1585.
210. Chandalia M, Abate N, Garg A, Stray-Gundersen J, Grundy SM. Relationship between generalized and upper body obesity to insulin resistance in Asian Indian men. J Clin Endocrinol Metab 1999; 84(7): 2329–2335.
211. Enevoldsen LH, Simonsen L, Stallknecht B, Galbo H, Bulow J. In vivo human lipolytic activity in preper-itoneal and subdivisions of subcutaneous abdominal adipose tissue. Am J Physiol Endocrinol Metab 2001; 281(5):E1110-E1114.
212. Johnson JA, Fried SK, Pi-Sunyer FX, Albu JB. Impaired insulin action in subcutaneous adipocytes from women with visceral obesity. Am J Physiol Endocrinol Metab 2001; 280(1):E40-E49.
213. Mauriege P, Brochu M, Prud'homme D, Tremblay A, Nadeau A, Lemieux S, Despres JP. Is visceral adiposity a significant correlate of subcutaneous adipose cell lipolysis in men? J Clin Endocrinol Metab 1999; 84(2):736–742.
214. Weber RV, Buckley MC, Fried SK, Kral JG. Subcutaneous lipectomy causes a metabolic syndrome in hamsters. Am J Physiol Regul Integr Comp Physiol 2000; 279(3):R936-R943.
215. Terry RB, Stefanick ML, Haskell WL, Wood PD. Contributions of regional adipose tissue depots to plasma lipoprotein concentrations in overweight men and women: possible protective effects of thigh fat. Metabolism 1991; 40(7):733–740.
216. Reitman ML, Arioglu E, Gavrilova O, Taylor SI. Lipoatrophy revisited. Trends Endocrinol Metab 2000; 11(10):410–416.
217. Treuth MS, Hunter GR, Kekes-Szabo T, Weinsier RL, Goran MI, Berland L. Reduction in intraabdominal adipose tissue after strength training in older women. J Appl Physiol 1995; 78(4):1425–1431.
218. Despres JP, Pouliot MC, Moorjani S, Nadeau A, Tremblay A, Lupien PJ, Theriault G, Bouchard C. Loss of abdominal fat and metabolic response to exercise training in obese women. Am J Physiol 1991; 261(2 Pt 1):E159-E167.
219. Bosello O, Zamboni M, Armellini F, Zocca I, Bergamo AI, Smacchia C, Milani MP, Cominacini L. Modifications of abdominal fat and hepatic insulin clearance during severe caloric restriction. Ann Nutr Metab 1990; 34(6):359–365.
220. Fujioka S, Matsuzawa Y, Tokunaga K, Tarui S. Contribution of intra-abdominal fat accumulation to the impairment of glucose and lipid metabolism in human obesity. Metabolism 1987; 36(1): 54–59.
221. Gray DS, Fujioka K, Colletti PM, Kim H, Devine W, Cuyegkeng T, Pappas T. Magnetic resonance imaging used for determining fat distribution in obesity and diabetes. Am J Clin Nutr 1991; 54(4):623–627.
222. Stallone DD, Stunkard AJ, Wadden TA, Foster GD, Boorstein J, Arger P. Weight loss and body fat distribution: a feasibility study using computed tomography. Int J Obes 1991; 15(11):775–780.
223. Armellini F, Zamboni M, Rigo L, Bergamo-Andreis IA, Robbi R, De Marchi M, Bosello O. Sonography detection of small intra-abdominal fat variations. Int J Obes 1991; 15(12):847–852.
224. Leenen R, Droop A, Seidell JC, Deurenberg P, Weststrate JA, Hautvast JG. Visceral fat loss measured by magnetic resonance imaging in relation to changes in serum lipid levels of obese men and women. Arterioscler Thromb 1993; 13(4):487–494.
225. Chowdhury B, Kvist H, Andersson B, Björntorp P, Sjöström L. CT-determined changes in adipose tissue distribution during a small weight reduction in obese males. Int J Obes Relat Metab Disord 1993; 17(12): 685–691.
226. Zamboni M, Armellini F, Turcato E, Todesco T, Bissoli L, Bergamo-Andreis IA, Bosello O. Effect of weight loss on regional body fat distribution in premenopausal women. Am J Clin Nutr 1993; 58(1): 29–34.
227. Nicklas BJ, Rogus EM, Goldberg AP. Exercise blunts declines in lipolysis and fat oxidation after dietary-induced weight loss in obese older women. Am J Physiol 1997; 273(1 Pt 1):E149-E155.
228. Zamboni M, Facchinetti R, Armellini F, Turcato E, Bergamo AI, Bosello O. Effects of visceral fat and weight loss on lipoprotein(a) concentration in subjects with obesity. Obes Res 1997; 5(4):332–337.
229. Janand-Delenne B, Chagnaud C, Raccah D, Alessi MC, Juhan-Vague I, Vague P. Visceral fat as a main determinant of plasminogen activator inhibitor 1 level in women. Int J Obes Relat Metab Disord 1998; 22(4): 312–317.
230. Goodpaster BH, Kelley DE, Wing RR, Meier A, Thaete FL. Effects of weight loss on regional fat distribution and insulin sensitivity in obesity. Diabetes 1999; 48(4):839–847.
231. Janssen I, Ross R. Effects of sex on the change in visceral, subcutaneous adipose tissue and skeletal muscle in response to weight loss. Int J Obes Relat Metab Disord 1999; 23(10):1035–1046.
232. Kockx M, Leenen R, Seidell J, Princen HM, Kooistra T. Relationship between visceral fat and PAI-1 in overweight men and women before and after weight loss. Thromb Haemost 1999; 82(5):1490–1496.
233. Riches FM, Watts GF, Hua J, Stewart GR, Naoumova RP, Barrett PH. Reduction in visceral adipose tissue is associated with improvement in apolipo-protein B-100 metabolism in obese men. J Clin Endocrinol Metab 1999; 84(8):2854–2861.
234. Doucet E, St Pierre S, Almeras N, Mauriege P, Despres JP, Richard D, Bouchard C, Tremblay A. Fasting insulin levels influence plasma leptin levels independently from the contribution of adiposity: evidence from both a cross-sectional and an intervention study. J Clin Endocrinol Metab 1999; 85(11): 4231–4237.
235. Kamel EG, McNeill G, Van Wijk MC. Change in intra-abdominal adipose tissue volume during weight loss in obese men and women: correlation between magnetic resonance imaging and anthropometric measurements. Int J Obes Relat Metab Disord 2000; 24(5):607–613.